The Technical Analyst
The Oncology Institute, [TOI]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Care Facilities
The Oncology Institute, Price, Forecast, Insider, Ratings, Fundamentals & Signals
-2.97% $1.145
America/New_York / 26 apr 2024 @ 13:36
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 85.09 mill |
| EPS: | -0.920 |
| P/E: | -1.240 |
| Earnings Date: | May 14, 2024 |
| SharesOutstanding: | 74.31 mill |
| Avg Daily Volume: | 0.111 mill |
| RATING 2024-04-26 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Strong Buy | |
| P/E: | Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -1.240 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.04x |
| Company: PE -1.240 | industry: PE 28.38 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.972 - 1.318 ( +/- 15.11%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-01-29 | Havencrest Healthcare Partners, L.p. | Sell | 8 637 | Common stock |
| 2024-01-24 | Havencrest Healthcare Partners, L.p. | Sell | 24 915 | Common stock |
| 2024-01-25 | Havencrest Healthcare Partners, L.p. | Sell | 11 882 | Common stock |
| 2024-01-26 | Havencrest Healthcare Partners, L.p. | Sell | 6 979 | Common stock |
| 2024-01-19 | Havencrest Healthcare Partners, L.p. | Sell | 11 986 | Common stock |
| INSIDER POWER |
|---|
| -56.96 |
| Last 99 transactions |
| Buy: 4 729 076 | Sell: 9 614 245 |
Forecast:
15:16 - $1.142
Live Trading Signals (every 1 min)
Forecast
1: 13:46 - $1.139
Forecast 2: 14:36 - $1.146
Forecast 3: 15:16 - $1.142
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $1.145 (-2.97% ) |
| Volume | 0.0712 mill |
| Avg. Vol. | 0.111 mill |
| % of Avg. Vol | 64.27 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For TOI
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
TOI
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
Latest Press Releases
2024-04-04 08:00:00 - Press Release
The Oncology Institute And Healthly Forge Strategic Alliance To Elevate Cancer Care Access To Healthly Patients Across Southern California
Cerritos, calif., april 04, 2024 (globe newswire) -- the oncology institute, inc. and its affiliates (nasdaq: toi) and healthly, a rapidly growing healthcare company with over 180 primary care physicians, support services, and a focus on preventive medicine, have announced a strategic collaboration aimed at extending high-quality cancer care services to patients throughout southern california. commencing july 1, 2024, toi will offer its cancer care services to patients affiliated with healthly's medical groups and associated physicians across the region. leveraging toi's extensive network of oncology clinics and providers, this partnership aims to deliver convenient and comprehensive cancer care services to patients within the healthly network.
2024-03-27 16:05:00 - Press Release
The Oncology Institute Reports Fourth Quarter And Full Year 2023 Financial Results And Guidance For 2024
Cerritos, calif., march 27, 2024 (globe newswire) -- the oncology institute, inc. (nasdaq: toi) (“toi” or the “company”), one of the largest value-based community oncology groups in the united states, today reported financial results for its fourth quarter and year ended december 31, 2023.
2024-03-14 08:09:00 - Press Release
Maxhealth & The Oncology Institute Expand Value-based Care Partnership
Toi announces clinical and financial accountability for maxhealth oncology care in 5 florida counties toi announces clinical and financial accountability for maxhealth oncology care in 5 florida counties
2024-03-06 08:00:00 - Press Release
The Oncology Institute Announces Fourth Quarter And Full Year 2023 Earnings Release Date And Conference Call
Cerritos, calif., march 06, 2024 (globe newswire) -- the oncology institute, llc (“toi”) (nasdaq: toi), one of the largest value-based oncology groups in the united states, today announced that the company will release its fourth quarter and full year 2023 financial results after the market close on wednesday, march 27, 2024, to be followed by a conference call the same day at 5:00 p.m. (eastern time).
2024-02-27 16:05:00 - Press Release
The Oncology Institute To Participate At Upcoming Investor Conferences
Cerritos, calif., feb. 27, 2024 (globe newswire) -- the oncology institute, inc. (nasdaq: toi), one of the largest value-based oncology practices in the country, today announced that dr. daniel virnich, toi's chief executive officer, will participate at the following investor conferences:
Latest News
2024-03-21 10:35:17 - Zacks Investment Research
Down -23.64% in 4 Weeks, Here's Why The Oncology Institute (TOI) Looks Ripe for a Turnaround
The Oncology Institute (TOI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
2024-03-06 08:00:00 - GlobeNewsWire
The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call
CERRITOS, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that the company will release its fourth quarter and full year 2023 financial results after the market close on Wednesday, March 27, 2024, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
2023-12-19 10:11:12 - PennyStocks
Penny Stocks To Buy Now? 4 To Watch Before 2024
As we enter 2024, investors wonder if it will be another volatile year for stocks. Maybe we see some stabilization after 2023's ups and downs; maybe not.
2023-11-10 03:25:07 - Seeking Alpha
The Oncology Institute, Inc. (TOI) Q3 2023 Earnings Call Transcript
The Oncology Institute, Inc. (NASDAQ:TOI ) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Dan Virnich - Chief Executive Officer Mihir Shah - Chief Financial Officer Conference Call Participants Jack Slevin - Jefferies Operator Good afternoon, and welcome to The Oncology Institute Third Quarter 2023 earnings conference call. Today's call is being recorded, and we have allocated one hour for prepared remarks and Q&A.
2023-10-18 08:03:00 - GlobeNewsWire
The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference Call
CERRITOS, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that the company will release its third quarter 2023 financial results after the market close on Wednesday, November 8, 2023, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
2023-09-26 16:05:00 - GlobeNewsWire
The Oncology Institute Executive Leaders to Present at the 2023 Association for Value-Based Cancer Care (AVBCC) Summit
CERRITOS, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (TOI) is excited to announce that multiple executives including CEO, Dr. Daniel Virnich, CMO, Dr. Yale Podnos, and other senior clinical leaders, will be participating in the Association for Value-Based Cancer Care (AVBCC) Summit.
2023-08-11 10:18:09 - Seeking Alpha
The Oncology Institute, Inc. (TOI) Q2 2023 Earnings Call Transcript
The Oncology Institute, Inc. (NASDAQ:TOI ) Q2 2023 Earnings Conference Call August 8, 2023 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Dan Virnich - Chief Executive Officer Mihir Shah - Chief Financial Officer Conference Call Participants Taji Phillips - Jefferies Operator Good afternoon ladies and gentlemen and welcome to The Oncology Institute's Second Quarter 2023 Earnings Conference Call. Today's call is being recorded and we have allocated one hour for prepared remarks and Q&A.
2023-07-18 08:00:00 - GlobeNewsWire
The Oncology Institute Announces Second Quarter 2023 Earnings Release Date and Conference Call
CERRITOS, Calif., July 18, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its second quarter 2023 financial results after the market close on Tuesday, August 8, 2023, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
2023-06-13 09:19:18 - InvestorPlace
3 Penny Stocks That Have Game-Changing Technologies
The NASDAQ index led the market out of technical bear market territory. And if the rally is going to have legs, investors will know they have artificial intelligence ( AI ) to thank for it.
2023-04-19 08:00:00 - GlobeNewsWire
The Oncology Institute Announces First Quarter 2023 Earnings Release Date and Conference Call
CERRITOS, Calif., April 19, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its first quarter 2023 financial results after the market close on Wednesday, May 10, 2023, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).